North American startup funding hit an unprecedented $392 billion in the first half of 2026, shattering previous records and cementing artificial intelligence as the dominant capital magnet. Yet beneath this headline triumph lies a deeply uneven distribution: AI startups are consuming the lion's share of venture dollars while traditional sectors struggle for relevance. Cleantech, once a venture darling, attracted only $15 billion across seed through growth-stage rounds—a recovery from 2025's lows but still marginal compared to the AI boom. For investors tracking sector health, the numbers tell a cautionary tale: when one technology sector commands an outsized percentage of a record funding pool, it signals not broadly distributed opportunity but rather a crowding dynamic that leaves non-AI founders navigating a relative famine.

The concentration problem extends beyond sector selection to investor behavior itself. Limited partners, spooked by economic uncertainty, have increasingly funneled capital into megafunds—the perceived safe harbor of venture investing. This preference paradoxically sacrifices the higher-risk, higher-upside bets that venture capital was designed to capture. Chemistry Ventures, the fund launched by alumni from Bessemer, Index Ventures, and Andreessen Horowitz, is raising $500 million for its second fund, representing the kind of boutique-to-substantial-scale transition that characterizes the current market. Yet firms like Chemistry remain exceptions; most emerging managers face LP pressure to grow or get out. The result is capital flowing predictably toward familiar names and established players, while founders in non-AI spaces find themselves explaining why their businesses aren't transformative language models.

Q2's active investor rankings underscore this dynamic: the same firms dominating deal flow in Q1 maintained their positions, reflecting both capital abundance and a herd mentality that masquerades as strategy. What's particularly telling is how few new entrants appear in top-tier rankings—a sign that venture's winnowing effect is accelerating. For founders and LPs alike, the $392 billion headline obscures an uncomfortable reality: record funding levels can coexist with reduced optionality. Non-AI sectors aren't starving, exactly, but they're increasingly dependent on smaller checks from smaller firms, while AI startups rake in nine-figure rounds from the same concentrated pool of megafunds. As one prominent observer noted, mistaking perceived safety for actual returns is a classic crowded-market error. The question for investors is whether H1 2026 represents a genuine boom or simply the latest stage of capital misallocation dressed up in record numbers.